Exploring Contrave : A Comprehensive Guide to this FDA-Approved Weight Loss Medication
Introduction Contrave is a medication approved by FDA in 2014 for chronic weight management in overweight (BMI ≥27 kg/m2) and obese (BMI ≥ 30 kg/m2) patients with at least one weight-related comorbidity. Qualifying weight-related comorbidities include cardiovascular disease (consisting of hypertension, dyslipidemia, or heart failure), prediabetes, type 2 diabetes mellitus, osteoarthritis, polycystic ovarian syndrome and…